Neuberger Berman Group LLC Takeda Pharmaceutical CO LTD Transaction History
Neuberger Berman Group LLC
- $123 Billion
- Q3 2024
A detailed history of Neuberger Berman Group LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Neuberger Berman Group LLC holds 16,594 shares of TAK stock, worth $223,023. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,594
Previous 10,494
58.13%
Holding current value
$223,023
Previous $135,000
74.07%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding TAK
# of Institutions
337Shares Held
73.8MCall Options Held
1.96MPut Options Held
165K-
Capital Research Global Investors Los Angeles, CA13.1MShares$177 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.35MShares$72 Million0.01% of portfolio
-
Mondrian Investment Partners LTD London, X05.09MShares$68.5 Million1.21% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA4.64MShares$62.3 Million0.05% of portfolio
-
Goldman Sachs Group Inc New York, NY4.56MShares$61.3 Million0.01% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $41.8B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...